McN-481

McN-481 designates a specific experimental compound developed by a team of researchers at McNeil Laboratories. It is a synthetic opioid analgesic, meaning it is a pain-relieving drug designed to mimic the effects of naturally occurring opioids. McN-481 is noted for its high potency and selectivity as a μ-opioid receptor agonist. Agonists activate receptors, and the μ-opioid receptor is the primary target for many pain medications. Due to its high potency, research involving McN-481 has primarily focused on understanding opioid receptor pharmacology and exploring potential applications in pain management under tightly controlled laboratory conditions. McN-481 is not currently approved for clinical use in humans. Further investigation is needed to fully characterize its safety profile and potential therapeutic benefits. The specific chemical structure and synthetic route of McN-481 are available in published scientific literature.